Mergers & Acquisitions
TCR2 Therapeutics
03/23
Âé¶¹´«Ã½ served as financial advisor for TCR2 Therapeutics Inc. on combination with Adaptimmune Therapeutics
Sub-Type
Merger
Sector
Sub-Sector
Biopharma